Unusual presentation of a mediastinal mass which grew slowly over 5 years, became aggressive and transformed into a high-grade lymphoma and presented as hypercalcemia
Keywords:
Lymphoma, Mediastinal mass, HypercalcemiaAbstract
A 62 year old male patient, without any co-morbid conditions, presented with an asymptomatic, slow-growing mediastinal mass since the past 5 years, that became aggressive and transformed into a high-grade lymphoma, with metastasis and presented as Hypercalcemia
References
Burke A, Virmani R. Atlas of Tumor Pathology (Third series, fascicle 16): Tumors of the Heart and Great Vessels. Washington: Armed Forces Institute of Pathology; 1996. pp. 171–9. [Google Scholar]
Ceresoli GL, Ferreri AJM, Bucci E, Ripa C, Ponzoni M, Villa E. Primary cardiac lymphoma in immunocompetent patients: Diagnostic and therapeutic management. Cancer. 1997;80:1497–506. [PubMed] [Google Scholar]
Nascimento AF, Winters GL, Pinkus GS. Primary cardiac lymphoma: Clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder. Am J Surg Pathol. 2007;31:1344–50. [PubMed] [Google Scholar]
Schell AJ, Xu Y, Baetz T, et al. Primary cardiac lymphoma: Molecular cytogenetic characterization of a rare entity. Cardiovasc Pathol. 2009;18:92–9. [PubMed] [Google Scholar]
Rolla G, Galligaris-Cappio F, Burke AP. Cardiac lymphomas. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. 1standn. Lyon: IARC Press; 2004. pp. 282–3. [Google Scholar]
Cwynarski K, et al. The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper. British Journal of Haematology, 2019. 185: 402–409.
Published
Issue
Section
License
Copyright (c) 2023 Bombay Hospital Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© The Author(s). 2024 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons. org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/ zero/1.0/) applies to the data made available in this article, unless otherwise stated.
